Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$10.98 - $11.65 $1,098 - $1,165
100 New
100 $1,000
Q4 2022

Feb 08, 2023

SELL
$10.2 - $10.5 $17,340 - $17,850
-1,700 Reduced 69.67%
740 $7,000
Q3 2022

Nov 10, 2022

BUY
$0.05 - $10.11 $58 - $11,899
1,177 Added 93.19%
2,440 $25,000
Q2 2022

Aug 10, 2022

SELL
$9.96 - $10.06 $3,814 - $3,852
-383 Reduced 23.27%
1,263 $13,000
Q1 2022

May 16, 2022

BUY
$9.85 - $9.96 $16,213 - $16,394
1,646 New
1,646 $16,000

About Monterey Bio Acquisition Corp


  • Ticker MTRY
  • Exchange NASDAQ
  • Sector Financial Services
  • Industry Shell Companies
  • Shares Outstandng 14,375,000
  • Description
  • Monterey Bio Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotech industry. The company was formerly known as Chardan FinTech Acquisition Corp. and change...
More about MTRY
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.